At Twin, we work to ensure that no one navigates this journey alone
Peptide therapy recommendations must be individualized based on your specific health status, goals, and risk factors.
A key 6-year follow-up study (N=266, elderly patients aged 60-89) published in Bulletin of Experimental Biology and Medicine demonstrated that Epithalamin treatment normalized melatonin production, improved T-cell immunity markers (CD3+, CD4+, CD4/CD8 ratio), and reduced cardiovascular mortality by 28% compared to the control group
The Phase 2 trial reported that 72% of participants with prediabetes at baseline reverted to normoglycemia
Most importantly, imagine being there and being able to take part in activities with your family, kids, and grandkids That's what our innovative weight loss program can offer you